Immuron IMRN
NASDAQ IMRN
$0.97 -0.05 (-4.71%)
As of: Oct 21, 2026 · 10:22 AM EDT

Immuron (IMRN) Finished Goods (2017 - 2026)

Updated

Immuron (IMRN) recorded Finished Goods of $392,013 in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 46.3% from $730,126 a year earlier.

Analysis

Immuron (IMRN) Finished Goods (2017 - 2026) Analysis & Trends

At the end of FY2026 (ended Jun 30, 2026), Immuron reported Finished Goods of $375,327, down 49.2% from FY2025.

  • Annual Finished Goods has a five-year compound annual growth rate of 11.4% (FY2021 to FY2026).
  • Across earlier fiscal years, Finished Goods came in at $738,900 in FY2025, $524,511 in FY2023 and $47,132 in FY2022 (-78.4%).
  • The fiscal Q4 2026 figure is the lowest quarterly Finished Goods since fiscal Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.38 Bn 1,098.96 Bn 19.71 Bn
2 Johnson & Johnson 613.84 Bn 532.37 Bn 17.26 Bn
3 AbbVie 502.13 Bn 475.24 Bn 12.70 Bn
4 Merck 367.76 Bn 322.14 Bn 12.21 Bn
5 Novartis Ag 298.08 Bn 262.07 Bn 11.24 Bn
6 Astrazeneca 262.03 Bn 235.71 Bn 12.86 Bn
7 Amgen 235.81 Bn 191.21 Bn 7.24 Bn
8 Gilead Sciences 190.97 Bn 165.17 Bn 6.22 Bn
9 Pfizer 169.66 Bn 116.31 Bn 10.94 Bn
10 Immuron 7.22 Mn -9.93 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 380,345.41
Jun 30, 2025 744,819.18
Dec 31, 2023 550,003.38
Jun 30, 2023 261,068.82
Dec 31, 2020 574,084.00
Jun 30, 2020 467,368.06
Dec 31, 2019 485,641.00
Jun 30, 2019 88,371.62
Dec 31, 2018 235,726.00
Aug 30, 2018 265,692.00
Jun 30, 2018 195,189.54
Jun 30, 2017 274,729.48
API Access

Immuron Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=IMRN&period=max&api_key=YOUR_API_KEY